---

2004 年

Mizuki M, Ueda S, Matsumura I, Ishiko J, Kanakura Y.
Kit mutations in hematopoietic malignancies. Gastrointestinal Stromal Tumor (GIST): From Pathology to Molecular Target Therapy (edited by Yukihiko Kitamura, Markku Miettinenn, Seiichi Hirota, Yuzuru Kanakura),
Japan Scientific Societies Press, Tokyo, 2004, pp91-105

Oritani K, Tomiyama Y.
Interferon-zeta/limitin: novel type I interferon that displays a narrow range of biological activity.
Int J Hematol 80:325-331, 2004.

Shibayama H, Takai E, Matsumura I, Kouno M, Morii E, Kitamura Y, Takeda J, Kanakura Y.
Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis.
J Exp Med 199:581-592, 2004.

Kashiwagi H, Shiraga M, Honda S, Kosugi S, Kamae T, Kato H, Kurata Y, Tomiyama Y.
Activation of integrin αIIbβ3 in the glycoprotein-Ib high population of a megakaryocytic cell line, CMK, by inside-out signaling.
J Thromb Haemost 2: 177-186, 2004

Ezoe S, Matsumura I, Satoh Y, Tanaka H, Kanakura Y.
Cell cycle regulation in hematopoietic stem/progenitor cells.
Cell Cycle 3:314-318, 2004

Satoh Y, Matsumura I, Tanaka H, Ezoe S, Sugahara H, Mizuki M, Shibayama H, Ishiko E, Ishiko J, Nakajima K, Kanakura Y.
Roles for c-Myc in self-renewal of hematopoietic stem cells.
J Biol Chem 279:24986-24993, 2004

Nakata S, Matsumura I, Tanaka H, Ezoe S, Satoh Y, Ishikawa J, Era T, Kanakura Y.
NF-κB Family Proteins Participate in Multiple Steps of Hematopoiesis through Elimination of Reactive Oxygen Species.
J Biol Chem 279:55578-55586, 2004

Nojima J, Kuratsune H, Suehisa E, Kitani T, Iwatani Y, Kanakura Y.
Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro.
Thromb Haemost 91:967-976, 2004

Sugahara H, Mizuki M, Matsumae S, Nabetani Y, Kikuchi M, Kanakura Y.
Footwear exchange has no influence on the incidence of febrile neutropenia in patients undergoing chemotherapy for hematologic malignancies.
Infect Control Hosp Epidemiol 25:51-54, 2004

Nishimura J, Kanakura Y, Ware RE, Shichishima T, Nakakuma H, Ninomiya H, Decastro CM, Hall S, Kanamaru A, Sullivan KM, Mizoguchi H, Omine M, Kinoshita T, Rosse WF.
Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan.
Medicine(Baltimore) 83:193-207, 2004

Hayashi S, Ichihara K, Kanakura Y, Iwatani Y.
A new quality control method based on a moving average of“latent reference values” selected from patients’ daily test results.
Rinsho Byori 52:204-211, 2004

Watanabe D, Ezoe S, Fujimoto M, Kimura A, Saito Y, Nagai H, Tachibana I, Matsumura I, Tanaka T, Kanegane H, Miyawaki T, Emi M, Kanakura Y, Kawase I, Naka T, Kishimoto T.
Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines.
Br J Haematol 126:726-735, 2004

Freson K, Hashimoto H, Thys C, Wittevrongel C, Danloy S, Morita Y, Shintani N, Tomiyama Y, Vermylen J, Hoylaerts MF, Baba A, Van Geet C.
The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation.
J Clin Invest 113:905-912, 2004

Honda S, Kashiwagi H, Kiyoi T, Kato H, Kosugi S, Shiraga M, Kurata Y, Tomiyama Y.
Amino acid mutagenesis within ligand-binding loops in αv confers loss-of-function or gain-of-function phenotype on integrin αvβ3.
Thromb Haemost 92:1092-1098, 2004


Kawamoto S, Oritani K, Asakura E, Ishikawa J, Koyama M, Miyano K, Iwamoto M, Yasuda S, Nakakubo H, Hirayama F, Ishida N, Ujiie H, Masaie H, Tomiyama Y.
A new interferon, limitin, displays equivalent immunomodulatory and antitumor activities without myelosuppressive properties as compared with interferon-alpha.
Exp Hematol 32:797-805, 2004

Yamada M, Oritani K, Kaisho T, Ishikawa J, Yoshida H, Takahashi I, Kawamoto S, Ishida N, Ujiie H, Masaie H, Botto M, Tomiyama Y, Matsuzawa Y.
Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells.
Eur J Immunol 34:221-230, 2004

Murayama Y, Miyagawa J, Oritani K, Yoshida H, Yamamoto K, Kishida O, Miyazaki T, Tsutsui S, Kiyohara T, Miyazaki Y, Higashiyama S, Matsuzawa Y, Shinomura Y.
CD9-mediated activation of the p46 Shc isoform leads to apoptosis in cancer cells.
J Cell Sci 117:3379-3388, 2004

Muromoto R, Sugiyama K, Takachi A, Imoto S, Sato N, Yamamoto T, Oritani K, Shimoda K, Matsuda T.
Physical and functional interactions between Daxx and DNA methyltransferase 1-associated protein, DMAP1.
J Immunol 172:2985-2993, 2004

Muromoto R, Sugiyama K, Yamamoto T, Oritani K, Shimoda K, Matsuda T.
Physical and functional interactions between Daxx and TSG101.
Biochem Biophys Res Commun 316:827-833, 2004

Kawakami M, Kimura T, Kishimoto Y, Tatekawa T, Baba Y, Nishizaki T, Matsuzaki N, Taniguchi Y, Yoshihara S, Ikegame K, Shirakata T, Nishida S, Masuda T, Hosen N, Tsuboi A, Oji Y, Oka Y, Ogawa H, Sonoda Y, Sugiyama H, Kawase I, Soma T.
Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38- cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells.
Leukemia 18:912-921, 2004

Nakajima H, Kawasaki K, Oka Y, Tsuboi A, Kawakami M, Ikegame K, Hoshida Y, Fujiki F, Nakano A, Masuda T, Wu F, Taniguchi Y, Yoshihara S, Elisseeva OA, Oji Y, Ogawa H, Azuma I, Kawase I, Aozasa K, Sugiyama H.
WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone.
Cancer Immunol Immunother 53:617-24, 2004

Ogawa H, Ikegame K, Kawakami M, Takahashi S, Sakamaki H, Karasuno T, Sao H, Kodera Y, Hirabayashi N, Okamoto S, Harada M, Iwato K, Maruta A, Tanimoto M, Kawa K.
Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: a large-scale retrospective analysis of data from the Japan Society for Hematopoietic Cell Transplantation.
Int J Hematol 79:495-500, 2004

Ogawa H, Ikegame K, Kawakami M, Tamaki H.
WT1 gene transcript assay for relapse in acute leukemia after transplantation.
Leuk Lymphoma 45:1747-1753, 2004

Ogawa H, Ikegame K, Kawakami M, Tsuboi A, Kim EH, Hosen N, Murakami M, Fujioka T, Masuda T, Taniguchi Y, Yoshihara S, Tatekawa T, Oka Y, Kawase I, Soma T, Oji Y.
Powerful graft-versus-leukemia effects exerted by HLA-haploidentical grafts engrafted with a reduced-intensity regimen for relapse following myeloablative HLA-matched transplantation.
Transplantation 78:488-489, 2004

Oji Y, Nakamori S, Fujikawa M, Nakatsuka S, Yokota A, Tatsumi N, Abeno S, Ikeba A, Takashima S, Tsujie M, Yamamoto H, Sakon M, Nezu R, Kawano K, Nishida S, Ikegame K, Kawakami M, Tsuboi A, Oka Y, Yoshikawa K, Aozasa K, Monden M, Sugiyama H.
Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma.
Cancer Sci 95:583-587, 2004

Oka Y, Tsuboi A, Taguchi T, Osaki T, Kyo T, Nakajima H, Elisseeva OA, Oji Y, Kawakami M, Ikegame K, Hosen N, Yoshihara S, Wu F, Fujiki F, Murakami M, Masuda T, Nishida S, Shirakata T, Nakatsuka S, Sasaki A, Udaka K, Dohy H, Aozasa K, Noguchi S, Kawase I, Sugiyama H.
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.
Proc Natl Acad Sci USA 101:13885-13890, 2004

Tamaki H, Kawakami M, Ikegame K, Iio K, Harada Y, Hatanaka K, Oka Y, Kawase I, Ogawa H.
Successful treatment of tacrolimus (FK506)-related leukoencephalopathy with cerebral hemorrhage in a patient who underwent nonmyeloablative stem cell transplantation.
Int J Hematol 80:291-294, 2004

Yoshihara S, Kato R, Inoue T, Miyagawa H, Sashihara J, Kawakami M, Ikegame K, Oka Y, Sugiyama H, Kawase I, Ogawa H.
Successful treatment of life-threatening human herpesvirus-6 encephalitis with donor lymphocyte infusion in a patient who had undergone human leukocyte antigen-haploidentical nonmyeloablative stem cell transplantation.
Transplantation 77:835-838, 2004


Oji Y, Miyoshi Y, Kiyotoh E, Koga S, Nakano Y, Ando A, Hosen N, Tsuboi A, Kawakami M, Ikegame K, Oka Y, Ogawa H, Noguchi S, Sugiyama H.
Absence of mutations in the Wilms' tumor gene WT1 in primary breast cancer.
Jpn J Clin Oncol 34:74-77, 2004

Tsuboi A, Oka Y, Osaki T, Kumagai T, Tachibana I, Hayashi S, Murakami M, Nakajima H, Elisseeva OA, Fei W, Masuda T, Yasukawa M, Oji Y, Kawakami M, Hosen N, Ikegame K, Yoshihara S, Udaka K, Nakatsuka S, Aozasa K, Kawase I, Sugiyama H.
WT1 peptide-based immunotherapy for patients with lung cancer: report of two cases.
Microbiol Immunol 48:175-184, 2004

Ogawa H, Ikegame K, Kawakami M, Taniguchi Y, Oka Y, Kawase I.
Allogeneic bone marrow transplantation with non-T-cell-depleted marrow from two HLA-antigen-mismatched related donors.
Haematologica 89:373-375, 2004

Oji Y, Miyoshi S, Takahashi E, Koga S, Nakano Y, Shintani Y, Hirabayashi H, Matsumura A, Iuchi K, Ito K, Kishimoto Y, Tsuboi A, Ikegame K, Hosen N, Oka Y, Ogawa H, Maeda H, Hayashi S, Kawase I, Sugiyama H.
Absence of mutations in the Wilms' tumor gene wt1 in de novo non-small cell lung cancers.
Neoplasma 51:17-20, 2004

Nakajima H, Kawasaki K, Oka Y, Tsuboi A, Kawakami M, Ikegame K, Hoshida Y, Fujiki F, Nakano A, Masuda T, Wu F, Taniguchi Y, Yoshihara S, Elisseeva OA, Oji Y, Ogawa H, Azuma I, Kawase I, Aozasa K, Sugiyama H.
WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone.
Cancer Immunol Immunother 53:617-624, 2004

Hosen N, Yanagihara M, Nakazawa T, Kanato K, Nishida S, Shirakata T, Asada M, Masuda T, Taniguchi Y, Kawakami M, Tsuboi A, Ikegame K, Oka Y, Ogawa H, Kawase I, Oji Y, Sugiyama H.
Identification of a gene element essential for leukemia-specific expression of transgenes.
Leukemia 18:415-419, 2004

Kolar GR, Yokota T, Rossi MID, Nath SK, Capra JD.
Human fetal, cord blood, and adult lymphocyte progenitors have silmilar potential for generating B cells with a diverse immunoglobulin repertoire.
Blood 104:2981-2987, 2004